nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—Doxorubicin—stomach cancer	0.658	1	CbGbCtD
Lubiprostone—CLCN2—blood vessel—stomach cancer	0.0265	0.31	CbGeAlD
Lubiprostone—CLCN2—epithelium—stomach cancer	0.0129	0.151	CbGeAlD
Lubiprostone—CLCN2—smooth muscle tissue—stomach cancer	0.0124	0.145	CbGeAlD
Lubiprostone—CLCN2—Stimuli-sensing channels—CLCN3—stomach cancer	0.0123	0.186	CbGpPWpGaD
Lubiprostone—CLCN2—endocrine gland—stomach cancer	0.00812	0.0948	CbGeAlD
Lubiprostone—CLCN2—Ion channel transport—CLCN3—stomach cancer	0.00804	0.121	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—AKR1C3—stomach cancer	0.00674	0.101	CbGpPWpGaD
Lubiprostone—CLCN2—lymph node—stomach cancer	0.00561	0.0655	CbGeAlD
Lubiprostone—CBR1—lymphoid tissue—stomach cancer	0.00399	0.0466	CbGeAlD
Lubiprostone—CBR1—digestive system—stomach cancer	0.00394	0.046	CbGeAlD
Lubiprostone—CBR1—bone marrow—stomach cancer	0.00363	0.0424	CbGeAlD
Lubiprostone—CBR1—endocrine gland—stomach cancer	0.00325	0.038	CbGeAlD
Lubiprostone—CBR1—liver—stomach cancer	0.00293	0.0343	CbGeAlD
Lubiprostone—CBR1—Arachidonic acid metabolism—ALOX5—stomach cancer	0.00291	0.0438	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.0028	0.0421	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—BLVRB—stomach cancer	0.00253	0.0381	CbGpPWpGaD
Lubiprostone—CBR1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—stomach cancer	0.00252	0.0379	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—AKR1C3—stomach cancer	0.00243	0.0366	CbGpPWpGaD
Lubiprostone—CBR1—lymph node—stomach cancer	0.00225	0.0263	CbGeAlD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC1A2—stomach cancer	0.00122	0.0183	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—TGFA—stomach cancer	0.00118	0.0177	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—SERPINA1—stomach cancer	0.00116	0.0175	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—CYP2A6—stomach cancer	0.00106	0.016	CbGpPWpGaD
Lubiprostone—CBR1—Arachidonic acid metabolism—PTGS2—stomach cancer	0.000909	0.0137	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HBEGF—stomach cancer	0.000839	0.0126	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	0.000813	0.0122	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTP1—stomach cancer	0.000745	0.0112	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—HMOX1—stomach cancer	0.000734	0.0111	CbGpPWpGaD
Lubiprostone—CBR1—NRF2 pathway—GSTM1—stomach cancer	0.000684	0.0103	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	0.000681	0.0102	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ACAD8—stomach cancer	0.000562	0.00845	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—HMOX1—stomach cancer	0.000549	0.00827	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	0.000549	0.00826	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	0.000516	0.00777	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GMPR2—stomach cancer	0.000501	0.00753	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	0.000483	0.00727	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—RORA—stomach cancer	0.000477	0.00719	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—IDH3B—stomach cancer	0.000458	0.00689	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—SUCLG1—stomach cancer	0.000458	0.00689	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NDUFS1—stomach cancer	0.000426	0.00641	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NDUFV1—stomach cancer	0.000426	0.00641	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—APOA1—stomach cancer	0.000416	0.00627	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	0.000416	0.00626	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—BLVRB—stomach cancer	0.000379	0.00571	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PGLS—stomach cancer	0.000379	0.00571	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPAP2A—stomach cancer	0.000362	0.00545	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	0.000348	0.00524	CbGpPWpGaD
Lubiprostone—Decreased appetite—Fluorouracil—stomach cancer	0.000346	0.00182	CcSEcCtD
Lubiprostone—Dysgeusia—Docetaxel—stomach cancer	0.000344	0.00181	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000343	0.0018	CcSEcCtD
Lubiprostone—Abdominal distension—Epirubicin—stomach cancer	0.000343	0.0018	CcSEcCtD
Lubiprostone—Mental disorder—Capecitabine—stomach cancer	0.000343	0.0018	CcSEcCtD
Lubiprostone—Feeling abnormal—Irinotecan—stomach cancer	0.000342	0.0018	CcSEcCtD
Lubiprostone—Erythema—Capecitabine—stomach cancer	0.00034	0.00179	CcSEcCtD
Lubiprostone—Malnutrition—Capecitabine—stomach cancer	0.00034	0.00179	CcSEcCtD
Lubiprostone—Influenza—Epirubicin—stomach cancer	0.00034	0.00179	CcSEcCtD
Lubiprostone—Pain—Fluorouracil—stomach cancer	0.00034	0.00179	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Irinotecan—stomach cancer	0.000339	0.00178	CcSEcCtD
Lubiprostone—Muscle spasms—Docetaxel—stomach cancer	0.000338	0.00178	CcSEcCtD
Lubiprostone—Flatulence—Capecitabine—stomach cancer	0.000335	0.00176	CcSEcCtD
Lubiprostone—Dysgeusia—Capecitabine—stomach cancer	0.000333	0.00175	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—ALB—stomach cancer	0.00033	0.00496	CbGpPWpGaD
Lubiprostone—Abdominal pain—Irinotecan—stomach cancer	0.000328	0.00173	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Doxorubicin—stomach cancer	0.000328	0.00173	CcSEcCtD
Lubiprostone—Feeling abnormal—Fluorouracil—stomach cancer	0.000328	0.00172	CcSEcCtD
Lubiprostone—Muscle spasms—Capecitabine—stomach cancer	0.000327	0.00172	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CA1—stomach cancer	0.000323	0.00485	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CKB—stomach cancer	0.000323	0.00485	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NDUFA2—stomach cancer	0.000323	0.00485	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FBP1—stomach cancer	0.000323	0.00485	CbGpPWpGaD
Lubiprostone—Gastritis—Doxorubicin—stomach cancer	0.000323	0.0017	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Doxorubicin—stomach cancer	0.000321	0.00169	CcSEcCtD
Lubiprostone—Tremor—Capecitabine—stomach cancer	0.000319	0.00168	CcSEcCtD
Lubiprostone—Abdominal distension—Doxorubicin—stomach cancer	0.000317	0.00167	CcSEcCtD
Lubiprostone—Ill-defined disorder—Capecitabine—stomach cancer	0.000316	0.00166	CcSEcCtD
Lubiprostone—Syncope—Docetaxel—stomach cancer	0.000315	0.00166	CcSEcCtD
Lubiprostone—Influenza—Doxorubicin—stomach cancer	0.000315	0.00166	CcSEcCtD
Lubiprostone—Pollakiuria—Epirubicin—stomach cancer	0.000314	0.00165	CcSEcCtD
Lubiprostone—Palpitations—Docetaxel—stomach cancer	0.000311	0.00163	CcSEcCtD
Lubiprostone—Weight increased—Epirubicin—stomach cancer	0.00031	0.00163	CcSEcCtD
Lubiprostone—Loss of consciousness—Docetaxel—stomach cancer	0.000309	0.00162	CcSEcCtD
Lubiprostone—Malaise—Capecitabine—stomach cancer	0.000307	0.00161	CcSEcCtD
Lubiprostone—Cough—Docetaxel—stomach cancer	0.000307	0.00161	CcSEcCtD
Lubiprostone—Hypersensitivity—Irinotecan—stomach cancer	0.000306	0.00161	CcSEcCtD
Lubiprostone—Syncope—Capecitabine—stomach cancer	0.000305	0.0016	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLIN2—stomach cancer	0.000303	0.00456	CbGpPWpGaD
Lubiprostone—Palpitations—Capecitabine—stomach cancer	0.000301	0.00158	CcSEcCtD
Lubiprostone—Myalgia—Docetaxel—stomach cancer	0.000299	0.00157	CcSEcCtD
Lubiprostone—Chest pain—Docetaxel—stomach cancer	0.000299	0.00157	CcSEcCtD
Lubiprostone—Loss of consciousness—Capecitabine—stomach cancer	0.000299	0.00157	CcSEcCtD
Lubiprostone—Asthenia—Irinotecan—stomach cancer	0.000298	0.00157	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000297	0.00156	CcSEcCtD
Lubiprostone—Cough—Capecitabine—stomach cancer	0.000297	0.00156	CcSEcCtD
Lubiprostone—Urinary tract infection—Epirubicin—stomach cancer	0.000295	0.00155	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CA2—stomach cancer	0.000295	0.00444	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Fluorouracil—stomach cancer	0.000293	0.00154	CcSEcCtD
Lubiprostone—Dry mouth—Docetaxel—stomach cancer	0.000293	0.00154	CcSEcCtD
Lubiprostone—Pollakiuria—Doxorubicin—stomach cancer	0.000291	0.00153	CcSEcCtD
Lubiprostone—Myalgia—Capecitabine—stomach cancer	0.00029	0.00152	CcSEcCtD
Lubiprostone—Chest pain—Capecitabine—stomach cancer	0.00029	0.00152	CcSEcCtD
Lubiprostone—Anxiety—Capecitabine—stomach cancer	0.000289	0.00152	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000288	0.00151	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PGAM1—stomach cancer	0.000287	0.00433	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NT5E—stomach cancer	0.000287	0.00433	CbGpPWpGaD
Lubiprostone—Oedema—Docetaxel—stomach cancer	0.000287	0.00151	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—stomach cancer	0.000287	0.00151	CcSEcCtD
Lubiprostone—Discomfort—Capecitabine—stomach cancer	0.000286	0.00151	CcSEcCtD
Lubiprostone—Diarrhoea—Irinotecan—stomach cancer	0.000284	0.00149	CcSEcCtD
Lubiprostone—Dry mouth—Capecitabine—stomach cancer	0.000283	0.00149	CcSEcCtD
Lubiprostone—Shock—Docetaxel—stomach cancer	0.000282	0.00148	CcSEcCtD
Lubiprostone—Nervous system disorder—Docetaxel—stomach cancer	0.000281	0.00148	CcSEcCtD
Lubiprostone—Tachycardia—Docetaxel—stomach cancer	0.00028	0.00147	CcSEcCtD
Lubiprostone—Skin disorder—Docetaxel—stomach cancer	0.000279	0.00147	CcSEcCtD
Lubiprostone—Oedema—Capecitabine—stomach cancer	0.000278	0.00146	CcSEcCtD
Lubiprostone—Dizziness—Irinotecan—stomach cancer	0.000275	0.00144	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PLCE1—stomach cancer	0.000274	0.00413	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALDH7A1—stomach cancer	0.000274	0.00413	CbGpPWpGaD
Lubiprostone—Anorexia—Docetaxel—stomach cancer	0.000274	0.00144	CcSEcCtD
Lubiprostone—Shock—Capecitabine—stomach cancer	0.000273	0.00144	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—stomach cancer	0.000273	0.00143	CcSEcCtD
Lubiprostone—Nervous system disorder—Capecitabine—stomach cancer	0.000273	0.00143	CcSEcCtD
Lubiprostone—Diarrhoea—Fluorouracil—stomach cancer	0.000272	0.00143	CcSEcCtD
Lubiprostone—Tachycardia—Capecitabine—stomach cancer	0.000271	0.00143	CcSEcCtD
Lubiprostone—Skin disorder—Capecitabine—stomach cancer	0.00027	0.00142	CcSEcCtD
Lubiprostone—Hyperhidrosis—Capecitabine—stomach cancer	0.000269	0.00141	CcSEcCtD
Lubiprostone—Oedema peripheral—Epirubicin—stomach cancer	0.000268	0.00141	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—stomach cancer	0.000268	0.00141	CcSEcCtD
Lubiprostone—Anorexia—Capecitabine—stomach cancer	0.000265	0.00139	CcSEcCtD
Lubiprostone—Vomiting—Irinotecan—stomach cancer	0.000264	0.00139	CcSEcCtD
Lubiprostone—Dizziness—Fluorouracil—stomach cancer	0.000263	0.00138	CcSEcCtD
Lubiprostone—CBR1—Metabolism—UMPS—stomach cancer	0.000263	0.00396	CbGpPWpGaD
Lubiprostone—Mediastinal disorder—Methotrexate—stomach cancer	0.000262	0.00138	CcSEcCtD
Lubiprostone—Rash—Irinotecan—stomach cancer	0.000262	0.00138	CcSEcCtD
Lubiprostone—Dermatitis—Irinotecan—stomach cancer	0.000262	0.00137	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000261	0.00137	CcSEcCtD
Lubiprostone—Headache—Irinotecan—stomach cancer	0.00026	0.00137	CcSEcCtD
Lubiprostone—Dyspnoea—Docetaxel—stomach cancer	0.000256	0.00134	CcSEcCtD
Lubiprostone—Mental disorder—Methotrexate—stomach cancer	0.000255	0.00134	CcSEcCtD
Lubiprostone—Erythema—Methotrexate—stomach cancer	0.000253	0.00133	CcSEcCtD
Lubiprostone—Malnutrition—Methotrexate—stomach cancer	0.000253	0.00133	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000253	0.00133	CcSEcCtD
Lubiprostone—Vomiting—Fluorouracil—stomach cancer	0.000253	0.00133	CcSEcCtD
Lubiprostone—Dyspepsia—Docetaxel—stomach cancer	0.000253	0.00133	CcSEcCtD
Lubiprostone—Rash—Fluorouracil—stomach cancer	0.000251	0.00132	CcSEcCtD
Lubiprostone—Dermatitis—Fluorouracil—stomach cancer	0.00025	0.00132	CcSEcCtD
Lubiprostone—Decreased appetite—Docetaxel—stomach cancer	0.000249	0.00131	CcSEcCtD
Lubiprostone—Headache—Fluorouracil—stomach cancer	0.000249	0.00131	CcSEcCtD
Lubiprostone—Oedema peripheral—Doxorubicin—stomach cancer	0.000248	0.00131	CcSEcCtD
Lubiprostone—Dysgeusia—Methotrexate—stomach cancer	0.000248	0.0013	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Docetaxel—stomach cancer	0.000248	0.0013	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—stomach cancer	0.000248	0.0013	CcSEcCtD
Lubiprostone—Dyspnoea—Capecitabine—stomach cancer	0.000248	0.0013	CcSEcCtD
Lubiprostone—Fatigue—Docetaxel—stomach cancer	0.000247	0.0013	CcSEcCtD
Lubiprostone—Nausea—Irinotecan—stomach cancer	0.000247	0.0013	CcSEcCtD
Lubiprostone—Mediastinal disorder—Epirubicin—stomach cancer	0.000246	0.00129	CcSEcCtD
Lubiprostone—Constipation—Docetaxel—stomach cancer	0.000245	0.00129	CcSEcCtD
Lubiprostone—Pain—Docetaxel—stomach cancer	0.000245	0.00129	CcSEcCtD
Lubiprostone—Dyspepsia—Capecitabine—stomach cancer	0.000245	0.00129	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PDHA1—stomach cancer	0.000244	0.00368	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ECHS1—stomach cancer	0.000244	0.00368	CbGpPWpGaD
Lubiprostone—Decreased appetite—Capecitabine—stomach cancer	0.000242	0.00127	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Capecitabine—stomach cancer	0.00024	0.00126	CcSEcCtD
Lubiprostone—Fatigue—Capecitabine—stomach cancer	0.00024	0.00126	CcSEcCtD
Lubiprostone—Mental disorder—Epirubicin—stomach cancer	0.000239	0.00125	CcSEcCtD
Lubiprostone—Constipation—Capecitabine—stomach cancer	0.000238	0.00125	CcSEcCtD
Lubiprostone—Pain—Capecitabine—stomach cancer	0.000238	0.00125	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—stomach cancer	0.000237	0.00125	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—stomach cancer	0.000237	0.00125	CcSEcCtD
Lubiprostone—Feeling abnormal—Docetaxel—stomach cancer	0.000237	0.00124	CcSEcCtD
Lubiprostone—Nausea—Fluorouracil—stomach cancer	0.000236	0.00124	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methotrexate—stomach cancer	0.000235	0.00124	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Docetaxel—stomach cancer	0.000235	0.00123	CcSEcCtD
Lubiprostone—Flatulence—Epirubicin—stomach cancer	0.000234	0.00123	CcSEcCtD
Lubiprostone—Dysgeusia—Epirubicin—stomach cancer	0.000232	0.00122	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TYMP—stomach cancer	0.00023	0.00346	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—FADS1—stomach cancer	0.00023	0.00346	CbGpPWpGaD
Lubiprostone—Feeling abnormal—Capecitabine—stomach cancer	0.000229	0.0012	CcSEcCtD
Lubiprostone—Malaise—Methotrexate—stomach cancer	0.000229	0.0012	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—stomach cancer	0.000228	0.0012	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000227	0.00119	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—stomach cancer	0.000227	0.00119	CcSEcCtD
Lubiprostone—Abdominal pain—Docetaxel—stomach cancer	0.000227	0.00119	CcSEcCtD
Lubiprostone—Cough—Methotrexate—stomach cancer	0.000221	0.00116	CcSEcCtD
Lubiprostone—Mental disorder—Doxorubicin—stomach cancer	0.000221	0.00116	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—stomach cancer	0.00022	0.00116	CcSEcCtD
Lubiprostone—Abdominal pain—Capecitabine—stomach cancer	0.00022	0.00115	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—stomach cancer	0.000219	0.00115	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—stomach cancer	0.000219	0.00115	CcSEcCtD
Lubiprostone—Flatulence—Doxorubicin—stomach cancer	0.000216	0.00114	CcSEcCtD
Lubiprostone—Chest pain—Methotrexate—stomach cancer	0.000216	0.00113	CcSEcCtD
Lubiprostone—Myalgia—Methotrexate—stomach cancer	0.000216	0.00113	CcSEcCtD
Lubiprostone—CBR1—Metabolism—SREBF2—stomach cancer	0.000215	0.00324	CbGpPWpGaD
Lubiprostone—Dysgeusia—Doxorubicin—stomach cancer	0.000215	0.00113	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000214	0.00113	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—stomach cancer	0.000214	0.00112	CcSEcCtD
Lubiprostone—Discomfort—Methotrexate—stomach cancer	0.000213	0.00112	CcSEcCtD
Lubiprostone—Syncope—Epirubicin—stomach cancer	0.000213	0.00112	CcSEcCtD
Lubiprostone—CBR1—Metabolism—RORA—stomach cancer	0.000213	0.0032	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Docetaxel—stomach cancer	0.000211	0.00111	CcSEcCtD
Lubiprostone—Muscle spasms—Doxorubicin—stomach cancer	0.000211	0.00111	CcSEcCtD
Lubiprostone—Palpitations—Epirubicin—stomach cancer	0.00021	0.0011	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—stomach cancer	0.000208	0.0011	CcSEcCtD
Lubiprostone—Cough—Epirubicin—stomach cancer	0.000207	0.00109	CcSEcCtD
Lubiprostone—Asthenia—Docetaxel—stomach cancer	0.000206	0.00108	CcSEcCtD
Lubiprostone—Hypersensitivity—Capecitabine—stomach cancer	0.000205	0.00108	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000204	0.00107	CcSEcCtD
Lubiprostone—Nervous system disorder—Methotrexate—stomach cancer	0.000203	0.00107	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—stomach cancer	0.000202	0.00106	CcSEcCtD
Lubiprostone—Myalgia—Epirubicin—stomach cancer	0.000202	0.00106	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—stomach cancer	0.000201	0.00106	CcSEcCtD
Lubiprostone—Skin disorder—Methotrexate—stomach cancer	0.000201	0.00106	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000201	0.00105	CcSEcCtD
Lubiprostone—Hyperhidrosis—Methotrexate—stomach cancer	0.0002	0.00105	CcSEcCtD
Lubiprostone—Discomfort—Epirubicin—stomach cancer	0.0002	0.00105	CcSEcCtD
Lubiprostone—Asthenia—Capecitabine—stomach cancer	0.000199	0.00105	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ALDOB—stomach cancer	0.000199	0.003	CbGpPWpGaD
Lubiprostone—Malaise—Doxorubicin—stomach cancer	0.000198	0.00104	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—stomach cancer	0.000197	0.00104	CcSEcCtD
Lubiprostone—Anorexia—Methotrexate—stomach cancer	0.000197	0.00104	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—stomach cancer	0.000197	0.00103	CcSEcCtD
Lubiprostone—Diarrhoea—Docetaxel—stomach cancer	0.000196	0.00103	CcSEcCtD
Lubiprostone—Palpitations—Doxorubicin—stomach cancer	0.000194	0.00102	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—stomach cancer	0.000194	0.00102	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—stomach cancer	0.000193	0.00101	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—stomach cancer	0.000192	0.00101	CcSEcCtD
Lubiprostone—Shock—Epirubicin—stomach cancer	0.00019	0.001	CcSEcCtD
Lubiprostone—Diarrhoea—Capecitabine—stomach cancer	0.00019	0.000999	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—stomach cancer	0.00019	0.000998	CcSEcCtD
Lubiprostone—Dizziness—Docetaxel—stomach cancer	0.00019	0.000998	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—stomach cancer	0.000189	0.000993	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000188	0.000991	CcSEcCtD
Lubiprostone—Skin disorder—Epirubicin—stomach cancer	0.000188	0.000988	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	0.000188	0.00283	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	0.000187	0.00282	CbGpPWpGaD
Lubiprostone—Hyperhidrosis—Epirubicin—stomach cancer	0.000187	0.000984	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—stomach cancer	0.000187	0.000982	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—stomach cancer	0.000187	0.000982	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—stomach cancer	0.000186	0.000979	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000186	0.000975	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ALOX5—stomach cancer	0.000185	0.00279	CbGpPWpGaD
Lubiprostone—Discomfort—Doxorubicin—stomach cancer	0.000185	0.00097	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—stomach cancer	0.000185	0.00097	CcSEcCtD
Lubiprostone—Dyspnoea—Methotrexate—stomach cancer	0.000184	0.000969	CcSEcCtD
Lubiprostone—Dizziness—Capecitabine—stomach cancer	0.000184	0.000966	CcSEcCtD
Lubiprostone—Dry mouth—Doxorubicin—stomach cancer	0.000183	0.000961	CcSEcCtD
Lubiprostone—Vomiting—Docetaxel—stomach cancer	0.000182	0.000959	CcSEcCtD
Lubiprostone—CBR1—Metabolism—DPYD—stomach cancer	0.000182	0.00274	CbGpPWpGaD
Lubiprostone—Dyspepsia—Methotrexate—stomach cancer	0.000182	0.000957	CcSEcCtD
Lubiprostone—Rash—Docetaxel—stomach cancer	0.000181	0.000951	CcSEcCtD
Lubiprostone—Dermatitis—Docetaxel—stomach cancer	0.000181	0.00095	CcSEcCtD
Lubiprostone—Decreased appetite—Methotrexate—stomach cancer	0.00018	0.000945	CcSEcCtD
Lubiprostone—Headache—Docetaxel—stomach cancer	0.00018	0.000945	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—stomach cancer	0.000179	0.000942	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000179	0.000939	CcSEcCtD
Lubiprostone—Fatigue—Methotrexate—stomach cancer	0.000178	0.000937	CcSEcCtD
Lubiprostone—Pain—Methotrexate—stomach cancer	0.000177	0.00093	CcSEcCtD
Lubiprostone—Vomiting—Capecitabine—stomach cancer	0.000177	0.000929	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000176	0.000927	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—stomach cancer	0.000176	0.000926	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—stomach cancer	0.000176	0.000923	CcSEcCtD
Lubiprostone—Rash—Capecitabine—stomach cancer	0.000175	0.000921	CcSEcCtD
Lubiprostone—Dermatitis—Capecitabine—stomach cancer	0.000175	0.00092	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—stomach cancer	0.000175	0.000919	CcSEcCtD
Lubiprostone—Headache—Capecitabine—stomach cancer	0.000174	0.000915	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—stomach cancer	0.000174	0.000915	CcSEcCtD
Lubiprostone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000173	0.00091	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—stomach cancer	0.000173	0.000907	CcSEcCtD
Lubiprostone—Anorexia—Doxorubicin—stomach cancer	0.000171	0.000897	CcSEcCtD
Lubiprostone—Nausea—Docetaxel—stomach cancer	0.00017	0.000896	CcSEcCtD
Lubiprostone—Feeling abnormal—Methotrexate—stomach cancer	0.00017	0.000896	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—stomach cancer	0.00017	0.000896	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000169	0.000889	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—stomach cancer	0.000168	0.000885	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000167	0.000878	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—stomach cancer	0.000167	0.000877	CcSEcCtD
Lubiprostone—Pain—Epirubicin—stomach cancer	0.000166	0.00087	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—stomach cancer	0.000166	0.00087	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	0.000165	0.00249	CbGpPWpGaD
Lubiprostone—Nausea—Capecitabine—stomach cancer	0.000165	0.000868	CcSEcCtD
Lubiprostone—Abdominal pain—Methotrexate—stomach cancer	0.000164	0.00086	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000163	0.000858	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTT1—stomach cancer	0.000161	0.00243	CbGpPWpGaD
Lubiprostone—Dyspnoea—Doxorubicin—stomach cancer	0.00016	0.000839	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—stomach cancer	0.00016	0.000839	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CYP2A6—stomach cancer	0.000159	0.0024	CbGpPWpGaD
Lubiprostone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000158	0.000832	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—stomach cancer	0.000158	0.000829	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—stomach cancer	0.000156	0.000818	CcSEcCtD
Lubiprostone—CBR1—Metabolism—AKR1C3—stomach cancer	0.000155	0.00233	CbGpPWpGaD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000155	0.000813	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—stomach cancer	0.000154	0.000812	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—stomach cancer	0.000153	0.000805	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—stomach cancer	0.000153	0.000805	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—stomach cancer	0.000153	0.000804	CcSEcCtD
Lubiprostone—Hypersensitivity—Methotrexate—stomach cancer	0.000152	0.000801	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ENO1—stomach cancer	0.000151	0.00227	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—ALB—stomach cancer	0.000149	0.00224	CbGpPWpGaD
Lubiprostone—Asthenia—Methotrexate—stomach cancer	0.000148	0.00078	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—stomach cancer	0.000148	0.000776	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.000146	0.00077	CcSEcCtD
Lubiprostone—Hypersensitivity—Epirubicin—stomach cancer	0.000143	0.00075	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—stomach cancer	0.000142	0.000744	CcSEcCtD
Lubiprostone—Diarrhoea—Methotrexate—stomach cancer	0.000142	0.000744	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—stomach cancer	0.000139	0.00073	CcSEcCtD
Lubiprostone—Dizziness—Methotrexate—stomach cancer	0.000137	0.000719	CcSEcCtD
Lubiprostone—CBR1—Metabolism—CD44—stomach cancer	0.000134	0.00202	CbGpPWpGaD
Lubiprostone—Diarrhoea—Epirubicin—stomach cancer	0.000132	0.000696	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—stomach cancer	0.000132	0.000694	CcSEcCtD
Lubiprostone—Vomiting—Methotrexate—stomach cancer	0.000132	0.000691	CcSEcCtD
Lubiprostone—Rash—Methotrexate—stomach cancer	0.00013	0.000686	CcSEcCtD
Lubiprostone—Dermatitis—Methotrexate—stomach cancer	0.00013	0.000685	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	0.00013	0.00196	CbGpPWpGaD
Lubiprostone—Headache—Methotrexate—stomach cancer	0.00013	0.000681	CcSEcCtD
Lubiprostone—Asthenia—Doxorubicin—stomach cancer	0.000129	0.000676	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—stomach cancer	0.000128	0.000673	CcSEcCtD
Lubiprostone—Vomiting—Epirubicin—stomach cancer	0.000123	0.000647	CcSEcCtD
Lubiprostone—Nausea—Methotrexate—stomach cancer	0.000123	0.000646	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—stomach cancer	0.000123	0.000644	CcSEcCtD
Lubiprostone—Rash—Epirubicin—stomach cancer	0.000122	0.000642	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—stomach cancer	0.000122	0.000641	CcSEcCtD
Lubiprostone—Headache—Epirubicin—stomach cancer	0.000121	0.000637	CcSEcCtD
Lubiprostone—Dizziness—Doxorubicin—stomach cancer	0.000118	0.000623	CcSEcCtD
Lubiprostone—Nausea—Epirubicin—stomach cancer	0.000115	0.000604	CcSEcCtD
Lubiprostone—Vomiting—Doxorubicin—stomach cancer	0.000114	0.000599	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PPP2R1A—stomach cancer	0.000114	0.00171	CbGpPWpGaD
Lubiprostone—Rash—Doxorubicin—stomach cancer	0.000113	0.000594	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—stomach cancer	0.000113	0.000593	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—stomach cancer	0.000112	0.00059	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GSTP1—stomach cancer	0.000112	0.00168	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—HMOX1—stomach cancer	0.00011	0.00166	CbGpPWpGaD
Lubiprostone—Nausea—Doxorubicin—stomach cancer	0.000106	0.000559	CcSEcCtD
Lubiprostone—CBR1—Metabolism—TYMS—stomach cancer	0.000104	0.00156	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—GSTM1—stomach cancer	0.000103	0.00154	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ERCC2—stomach cancer	9.65e-05	0.00145	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—MTHFR—stomach cancer	9.07e-05	0.00137	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—CAV1—stomach cancer	8.37e-05	0.00126	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—APOA1—stomach cancer	8.35e-05	0.00126	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	7.99e-05	0.0012	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PPARG—stomach cancer	7.36e-05	0.00111	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—ALB—stomach cancer	6.61e-05	0.000996	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—NOS3—stomach cancer	6.33e-05	0.000952	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PTGS2—stomach cancer	5.79e-05	0.000871	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism—PIK3CA—stomach cancer	3.56e-05	0.000536	CbGpPWpGaD
